Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Saved in:
Published in | ANNALS OF ONCOLOGY Vol. 33; no. 7; p. S1408 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Conference Proceeding |
Language | English |
Published |
2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0923-7534 |
---|---|
DOI: | 10.1016/j.annonc.2022.08.040 |